Hemoglobin A1c (HbAlc) measurements are important for monitoring glycemic control in patients with diabetes. The positive impact of point-of-care HbAlc measurements on patient management is described in the literature. The general analytical requirements for HbAlc testing are described. The analytical evaluation of a new point-of-care HbAlc analyzer, suitable for a physician's office, against these requirements is described.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. Sep 30; 329 (14): 977–86.
2.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. Sep 12; 352 (9131): 837–53.
3.
LittleRRRohlfingCLWiedmeyerHMMyersGLSacksDBGoldsteinDE; NGSP Steering Committee. The national glycohemoglobin standardization program: a five year progress report. Clin Chem. 2001 Nov; 47 (11): 1985–92.
4.
SteffesMClearyPGoldsteinDLittleRWiedmeyerHMRohlfingCEnglandJBucksaJNowickiM.Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study. Clin Chem. 2005 Apr; 51 (4): 753–8.
5.
SacksDBBrunsDEGoldsteinDEMaclarenNKMcDonaldJMParrottM.Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002 Mar; 48 (3): 436–72.
6.
KolatkarNSCembrowskiGSCallahanPLEtzwilerDD.Intensive diabetes management requires very precise testing of glycohemoglobin. Clin Chem. 1994 Aug; 40 (8): 1608–10.
7.
SheieSThueGSandbergS.Interpretation of hemoglobin A1c (HbA1c) values among diabetic patients: implications for quality specifications for HbAlc. Clin Chem. 2001;47 (7): 1212–7.
8.
PhillipouGPhillipsPJ.Intraindividual variation of glycohemoglobin: implications for interpretation and analytical goals. Clin Chem. 1993 Nov; 39 (11Pt 1): 2305–8.
9.
ShephardMDMazzahiBCShephardAKMcLaughlinKJDennerBBarnesG.The impact of point of care testing on diabetes services along Victoria's Malle Track: results of a community-based diabetes risk assessment and management program. Rural Remote Health. 2005 Jul-Sep; 5 (3): 371.
10.
CaglieroELevinaEVNathanDM.Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care. 1999 Nov; 22 (11): 1785–9.
11.
ThalerLMZiemerDCGallinaDLCookCBDunbarVGPhillipsLSEl-KebbiIM.Diabetes in urban African-Americans. XVII. Availability of rapid HbAlc measurements enhanced clinical decision-making. Diabetes Care. 1999 Sep; 22 (9): 1415–21.
12.
WikbladKSmideBBergströmAWahrenLMugusiFJeppssonJO.Immediate assessment of HbA1c under field conditions in Tanzania. Diabetes Res Clin Proc. 1998 May; 40 (2): 123–8.
13.
HigginsTN.Impact of point of care glucose, HbA1c and microalbumin/creatinine ratio on managing/diagnosing the diabetic patient. J Point Care. In press 2007.
